PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study.
暂无分享,去创建一个
P. Neužil | P. Serruys | P. Brugada | K. Kuck | G. Montalescot | W. Budts | A. Vahanian | P. Probst | L. Thuesen | W. Rużyłło | H. Sievert | J. Marco | A. Vahanian | A. Ramondo | E. Rowland | A. Bartorelli | H. Omran | M. Pichler | E. Fischer | S. Ostermayer | Y. Bayard | S. Ostermayer | J. Piéchaud | F. Büscheck | M. Leetz | Horst Sievert | Heyder Omran | Petr Neuzil | Leif Thuesen | Maximilian Pichler | Edward Rowland | Angelo Ramondo | Witold Rużyłło | Werner Budts | Gilles Montalescot | Pedro Brugada | Patrick Serruys | Antonio Bartorelli | Jean Marco | Peter Probst | Karl-Heinz Kuck | Evelyn Fischer | P. Serruys | K. Kuck | Antonio L. Bartorelli | W. Ruzyllo | P. Neužil | Werner Budts
[1] Maurice Buchbinder,et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.
[2] H. Sievert,et al. Percutaneous closure of the left atrial appendage: a major step forward. , 2009, JACC. Cardiovascular interventions.
[3] P. Teirstein,et al. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. , 2009, JACC. Cardiovascular interventions.
[4] M. Aguilar,et al. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.
[5] S. Ho,et al. Occluding the left atrial appendage: anatomical considerations , 2007, Heart.
[6] G. Schuler,et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. , 2007, Journal of the American College of Cardiology.
[7] R. Becker,et al. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. , 2005, Journal of the American College of Cardiology.
[8] P. Teirstein,et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. , 2005, Journal of the American College of Cardiology.
[9] B. Gage,et al. Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin , 2004, Circulation.
[10] Ottavio Alfieri,et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. , 2003, Journal of the American College of Cardiology.
[11] Carl van Walraven,et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. , 2002, JAMA.
[12] M. Eliasziw,et al. Occurrence of Hemispheric and Retinal Ischemia in Atrial Fibrillation Compared With Carotid Stenosis , 2002, Stroke.
[13] Hakan Oral,et al. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. , 2002, Journal of the American College of Cardiology.
[14] F. D. A. Costa,et al. Intervenções Percutâneas em Cardiopatias Congênitas , 2002 .
[15] M. Lesh,et al. Percutaneous Left Atrial Appendage Transcatheter Occlusion to Prevent Stroke in High-Risk Patients With Atrial Fibrillation: Early Clinical Experience , 2002, Circulation.
[16] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[17] B K Khandheria,et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. , 1997, Circulation.
[18] D. Singer,et al. National patterns of warfarin use in atrial fibrillation. , 1996, Archives of internal medicine.
[19] J. Odell,et al. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. , 1996, The Annals of thoracic surgery.
[20] G. Raskob,et al. Hemorrhagic complications of anticoagulant treatment. , 1992, Chest.
[21] P. Wolf,et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.
[22] J. Marshall,et al. Atrial Fibrillation, TIAs and Completed Strokes 441 , 1984, Stroke.
[23] Silvia G. Priori,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .